Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.

Saved in:
Bibliographic Details
Title: Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.
Authors: Weide B; Department of Dermatology, Division of Dermatooncology, University of Tübingen, Tübingen, Germany. benjamin.weide@med.uni-tuebingen.de, Pascolo S, Scheel B, Derhovanessian E, Pflugfelder A, Eigentler TK, Pawelec G, Hoerr I, Rammensee HG, Garbe C
Source: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2009 Jun; Vol. 32 (5), pp. 498-507.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-4513
DOI:10.1097/CJI.0b013e3181a00068